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in 9S%. There were 3 Q-wave infarcts (3%) and 1 death (1%). A non-Q-wave 
infarct was sustained by 610ts (5%) and 1 lot (1%) required emergency bypass 
surge~'. 
The pro and final MLO for both groups was 0.72 and 2.75 mm (diameter 
eten~ls of 76.8 and -11.4%). Patients were discharged on aspirin (ASA) and 
werfadn 54%, ASA and t i~ id ine  42%, or ASA, tioiopkiine and low molecular 
weight hepadn 4"/,,. Mean 18-month follow-up on 7"P/o demonstrated: t vget 
lesion retntervention 5%, CABG 3%, stunt thrombosis 0%, death 5%. 
Conclusion: Stunt deployment for suboptimal RA results or as an adjunct 
treatment of calcified coronary lesions provides excellent angiographic re- 
suits (-11.4% final etenosis') with few major procedural complications. 
r9-7-~-7-7-4--i coronary stunt  Implantation in Aorto-Ostlal 
Lesions: Immediate end Follow-up Results 
Antonio Colombo, Akim Iteh, Luigi Malello, Stmanefta Blengine, Carlo Di 
Made, Zamptsd Pa~fo, Lucia Di Francesco, Massimo Fenaro, 
Giovanni Martini, Leo Fincl. Columb,.-s Hospital, Milan, Italy 
Treatmem of aorto-oetial lesions by conventional balloon angioplesty and 
other new devious (laSer, atherectomy devices) is limited by high restenosis 
rates of up to 60=/0, This study evaluate immediate and long-term results of 
stem implantation in aorto.oetial lesions. We treated 35 astial lesions In 35 
patients (mean age 61 4.13 years, 88=/., males). The lesion distribu~on was: 
17 ostial RCA, 13 aspheneus vein graft aorto-ostlal anastomoses and 5 estlal 
Left Main lesions. Stem indications were: 23 elective (66%), 6 restenosis 
(17%), 5 s,JbOptimel PTCA result (14"/o) and 1 dissection (3%). Procedural 
success was aChieved in all attempted procedures. Retablater was performed 
prior to stunting in 6 patients. A total of 41 stants were implanted: 21 standard 
Palmaz-Schetz, 12 short Palmaz-Schatz, 6 bilimy Patmaz-Schata, 1 Wiktor 
and 1 Gianturoo-Roub|n stunt. Angiographic results are shown in the table: 
Baseline Post s tem Follow-up 
MLD (ram) 0.85 4- 0.62 3.51 4. 0.65 2.48 4. 0.83 
%Stanosis 75.2 4-17,8 -9.2 4. 22.9 26,1 4-19,3 
MLD - minimal lumen diameter 
Angiographic tollow-up was performed in ~J r~iients (69% of eligible 
patients) and restenosis occurred in 5 lesions (2"o'%). Conclusion: Stenting 
of suitable aorto-ostial lesions has favorable immediate and medium-term 
results and a I(~,ver estenosis rate compared to the hlstodcal group of 
patients having treatment by other interventions. 
~ A  Highly Signif icant 40% Reduction in lachemic 
Complications of  Percutaneous Coronary 
Intervention In 19~5: Beginning of  A New Era? 
Stephsn G. Ellis, Patrick L. Whitlow, ViCtor Guetta, W, Scott Sheldon, Edc 
J. Topoi. The Cleveland Clinic Foundation, Cleveland, OH 
1995 was marked in the U.S. intewentionel community by a dramatic upswing 
In the number ot patients (pts) treated (rx'd) with elective sterile, and the first 
availability of the anttplatalet agent ReoPro. At our center, physicians also 
were tracked for the first time by pt cost. By mid-year we noted a considerable 
reduction in ischemio events and this study was formally undertaken to 
assess differences in pt oemngraphlca nd outcome for 1995 compared to 
1993-94. Pte presenting with acute MI were excluded. 
1993-94 (n = 3732) 1-8/1995 (n - 1269) ,,p 
Age firs) 62 4-11 64 4-11 < 0,001 
Angina t re,3t (%) 41.7 43.1 0.36 
Most complex I~inn 82 or C (%) 58.5 51.0 < 0.001 
Elective stunt (%) 4,8 22.8 < 0.001 
ReoPro (%) 0.0 7.0 < 0.001 
Cardiao death (%) 0.8 0.6 0.61 
Emerg CABG (%) 1.4 0,8 0.06 
O wave Mt (%) 1.3 0,5 0.003 
Death, Q wave MI, Emerg CABG 3.0 1.7 0.004 
Logistic analysis disregarding any particular x, but correcting for 11 vari- 
ables [including most complex lesion: odds ratio (OR)/unit (A = 1, B1 = 2, B2 
= 3, C = 4) = 2.4, p < 0,001; pdor CABG:OR = 0.6, p = 0.005; and shock: 
OR - 3.1 p = 0.006] found rx in 1995 still to be related to dsk of death, MI or 
CABG (OR = 0.6, p = 0.05). Rx in 1995 became dearly unrelated to outcome 
(OR = 0.8, p = 0.28) when the vadable "stunting in 1995" was added. 
Conclusions: Complications of porcelaneous intervention appear to be 
reduced in 1995, possibly due to a decrease in lesion complexity, more 
elective stunting and ether factors. 
• Elective Coronary Stenting Versus Bal loon 
Angloplesty In Smaller Native Coronary Arteries: 
Results  From STRF.S~ 
Michael Savage, David Fischman, Randal Rake, Richard Schetz, fen Penn, 
Masakiyo Nobuyoshi, Jeffrey Moses, Richard Heuser, Sharon Gebhardt, 
Sheldon Goiolcorg for the STRESS Tdal Investigators. Jefferson Medical 
College, Philadelphia PA 
Palmaz-Schalz stunts have been designed and FDA-approved for large 
comneW arteries with diameters >_. 3.0 ram. The goal of this STRESS Trial 
substudy was to comp~e the egicacy of elective stem implantation and 
angioplasty (PTCA) for new lesions in smaller native coronary arteries. Of 
407 patients enrolled in this prospective random!zed trial, 214 (,5,~0) patients 
were determined by core laboretonj quantitative analysis to hove reference 
vessel dlametem < 3.0 ram. 111 patients were assigned to PTCA (mean 
diameter 2.65 ~- 0.24 ram) and 103 patients were -ssigned to stenting (mean 
diameter 2.71 4. 0.21 ram). Endpoints were analyzed by intention-to-treat. 
Bese(ine clinical ~ lesion charectsfistlcs were comparable for the two 
groupS. Abrupt closure (in or out of lab) occurred in 3(2.7"/o) patients Ip the 
PTCA group and 4(3.9%) patients in the stant group (p = ns). Minimal umen 
diameters in mm were as follows: 
Group Baseline Post Procedure 6 month F/U Net Gain 
PTCA 0.68:1:0.21 1.784-0.36 1.304-0.52 0.634-0.53 
Stem 0.72 4- 0.25 2.29 4- 0.38 1.56 ± 0.56 0.84 ± 0.59 
p ns <0.0001 0.001. 0.013 
Thus, stunting conferred a larger initial lumen which persisted after 6 
months. Restenosts (> 50% dian;eter ste~lnsis at foi;ow-up) occurred in 
44/84(52%) patients assigned to PTCA and in 3~'93(35%) patients assigned 
to stunting (p = 0.024). There were no significant differences in clinical events 
between the two groups. Target lesion revascutarizat~on was performed in 
25(23%) PTCA patients and 16(16%) stent patients (p = ns). In conclu- 
sion, the results of this STRESS Tdal substudy suggest that elective .~tent 
placement provides supedor angiogrephic outcome and less restenosis than 
PTCA in vessels slightly smaller than 3 ram. 
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~7-~'~ High Plasma Angiotensin-ConverUng Enzyme 
Levels, and Insell ion/Deletion Genotype Are 
Aesoclated With Reatenosla After Coronary 
Stenting 
Ravlo Ribtchini, Giusoppa Stalfenino, Antonio Dellavalle, 
Terenzio Camilla 1, Alberto Piazza 2, Gabfiella Benetton 2 Pine Malullo 2 
Eugenio Uslanghi. C.ard/ac Cathete~ation Unit, Italy; ~ Laboratory for 
Clinical Biochemistry, Ospedale S. Croce, Cuneo, Italy: 2 Ins~tute of Human 
Genetics, Univers;~ : ,of Turin, Italy 
Angiotansln-cenvarting enzyme (ACE) I/D ganotype does not appear to be 
consistently associated with restenosis attar balloon coronary angioptasty. 
The ACE genotypa determines plasma levels of the enzyme. Via Angioton- 
sin II, ACE can promote smooth muscle cell proliferation. This is reported 
to be the most important component of restenosts after coronary stenting 
(CS), but not after buffoon dilatation. We investigated the relationship be- 
tween ACE plasma levels, I/D ACE genutype, and tong-term restenosls after 
CS. 
Sixty-three consecutive patients (p) were treated with a first, elective, 
single-vassal CS. Basal plasma ACE levels were measured with a quan- 
titottve kinetic determination using FAPGG substrata (mean normal values 
30 + - 10 U/L), and a complete laboratory screening was obtained in all p. 
Amplification by polymerase chain reaction was used in the determination of 
ACE gone polymoqDhism. No p received ACE-inhibitor therapy thmughou; 
the study. Restanosls was defined as the presence of • 50% stenosis of 
the treated lesion, as measured with a Philips DCI Quantitative Coronary 
Angiogrephy system at 6-month angiographio follow-up. Plasma ACE lev- 
els and I/D golymorphtsm in p with and without restenosis were as follows 
(percentages in brackets): 
No. ACE(U/L) D/D UD 111 
Restanosls 13 47.3 4- I"P 11 (85)" 2 (15) 0 
No Restenosls 50 20.5 4-11 # 15 (30)" 25 (50) 10 (20) 
#p < 0.0001; Up < 0.001 
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No other signif!cant difference between the groups was found in the anal- 
ysis of the lipid profile, other serum parameters or smoking habits. 
In conclusion: Both high basal plasma levels of ACE, and D/D gsne pOly- 
morphism are associated with restenosls after Ca. 
inducible Nitric Oxide Synthsss Is Expressed 
Acutely In the Arterial Media Fol lowing Balloon 
Injury 
Addan R Banning, Lee Buttery 1, John Wharton 1 Patrick Black, 
Jennifer Polak 1, Malcolm J. Lewis. Cardiovascular Sciences Research 
Group, University Hospital of Wales, Cardiff, London, UK; 1 Dept 
Histochemlstry, Hammemmith Hospital, London, UK 
NO released by endothelial (e) NO synthase (NOS) inhibits pletetet aggrega- 
tion and leukocyte adhesion and may also influence vascular smooth muscle 
cell (VSMC) proliferation. Expression of inducible (i) NOS by macrophage 
and VSMCs may play an important and undefined role in events following 
angioplasty. 
Wo studied the effect of balloon inlury on NOS activity using immunohis- 
techemical staining and pH] labelled nitro-L-arginine (SH-L=NOARG) autore- 
diography. Pigs underwent bilateral camtid angioplasty and warn sacrificed 
at 24 hrs, 5 days, 7 days or 21 d~ys (n = 4 each group). Proliferating cell 
nuclear antigen (PCNA) expression indicated active VSMC division, eNOS 
and iNOS activities were measured using routine macrophage iNOS peptide 
and aortic endothelial cell NOS antfsara. 
Uninjured artedas exhibited ense pH]-L-NOARG binding and strong unl- 
term endothelial staining for eNOS along the whole luminal endothelium but 
no INOS activity. 24 hrs after injury endothelial denudation was complete and 
eNOS was absent at the luminal surface, marked iNOS activity was detected 
throughout the media reflecting INOS induction in VSMCs. 5 days after in- 
jury, some eNOS activity was de!actable at the lumen and iNOS activity was 
maximal in the forming neo-intimal layer. At 7 days (time of maximal intimal 
proliferation detected by PCNA) eNOS covered most of the luminal surface, 
with INOS activity only in the neointima, By 21 days (time of maximal Inti- 
real growth measured by cross sectional planimetry) [3H]-L-NOARG binding 
and eNOS staining were as in uninjured arteries. We conclude that iNOS is 
prominently expmased in the artedal media within 24 hrs of balloon injury 
NO. Release of NO by VSMCs may have an important role in the processes 
of neointima formation following balloon injury. 
~ ' ~  Intimsl Proliferation and Apoptosis  Fallowing 
Experimental Balloon Angloplssty 
Joachim Kamenz, Hartmut Hanks, Woifgang Saibold, Christina Lenz, 
Rainer Vofsard, Vinzenz Hombach. Dept. of Cardiology, University of Ulm 
Medical Center, Germany 
The aim of this study was to determine the occurrence of programmed cell 
death (apeptesis) in re!ation to the proliferative response in the Intlmal layer 
after experimental balloon angioplasty. After induction of an intimal plaque in 
the dght carotid artery by electrical stimulation, 26 rabbits underwent balloon 
angioplaety. Eight animals served as a control group without intervention. To 
study the time course of intimal apoptosls and sail pmliferation the vessels 
were exised 7,14 and 28 days after balloon angioplasty, For in-situ detection 
of apeptesis, the TUNEL-technique (TdT-mediated UTP-tiuoresceio nick 
end labeling) was used in order to allow the differentiation between inter- 
nucioosomai DNA-degredetion, typical for apoptosis, and the more random 
DNA destruction in necrosis. Results obtained with this molecular technique 
have been controlled by assessment of programmed cell death by moq0ho- 
logical cdteda. In addition, bromndeoxyuddine-labeling in all animals allowed 
the determlnetibn of coils undergoing DNA-synthesls in the neo-lntlmai rea 
in percent, Within 28 days after balloon angioplasty the number of cells un- 
dergoing apeptosls was not significantly different to the control group without 
interventionai treatment (controls: 0.07 4- 0.1%; 7 d: 0.18 4- 0.17%; 14 d: 
0.07 4- 0,07%; 28 d: 0,12 4- 0.06%). The number of cells undergoing DNA 
synthesis was significantly increased by day 7 after angioplasty (4.1 ± 1.5% 
vs. 0.6 4- 0.3% in controls), resulting in an intimal thickening from 02 4- 39 
/~m up to 242 4- 165/~m at 28 days following balloon dilatation, In contrast 
to an excessive increase of Inlimai proliferation, the present study indicates 
that the number of apoptutic elts remain on a very low level within 28 days 
after balloon angioplasty. Our data suggest that significant changes in the 
occurrence of apaptosls are probably not involved in the regulation of cellular 
turn-over dudng the early stage of vessel wall response after vascular injury. 
• Smooth Muscle Cell Proliferation, Growth and 
Migration In Primary and Restenotlc Human 
Coronary Atherosclerol ic Tissue 
Roger J. Laham, Richard E. Kuntz, Donald S. Balm, J. Anthony Ware, 
Henry Slaytor, Stuart J. Cchnitt, Isaac E. Stillman, Michael Simons. Harvard 
Medical School. Beth Israel Hospital, Boston, MA 
Both neointimal formation and artedai remodeling have been implicated as 
the pathological processes msponsibl3 for post-angioplasty restenosis. The 
purpose of this study was to pmspactively study the proliferation, growth, 
end migration of SMC in etheroscfemtic and restenotib tissue obtained from 
62 consecutive Pte (48 primary and 14 restenotic lesions) undergoing direo 
lionel comnary atherectemy. SH-Thymidine labeling indexed to the amount 
of DNA was used to determine the proliferative activity of the samples with 
EM-autoradlogrephio l calization. Immunocytochemical staining using MIB- 
1 antibody (specific for the KI-67 Antigen expressed by proliferating cells) 
was used to confirm the proliferative activity of SMC. In situ SMC growth 
charectedsties were determined by quantifying explant outgrowth of SMC, 
Intrinsic migratory activity of cultured SMC was determined in a modified 
micro Boyden chamber. 
The thymtdioe labeling index was slgnWcantly higher in restenotic than 
primary specimens (273,167 :b 49,621 vs 86,593 4- 8,550 CPM/DNA, p < 
0.0001). EM autoradiography localized the majority (> 60%) of thymidine 
uptake to the nuclei of SMC with < 2% of SMC demonstrating nuclear thymi- 
dine uptake. MIB-1 staining showed a higher proliferation index in restenotic 
specimens (1.95 4- 0.4% vs 0.58:1: 0.27%, p = 0.009). SMC cultured from 
restenotic specimens had higher growth rate than cells from pdmary spec- 
imens (Slopes: 24.16 vs 12.35, p = 0.001). The intrinsic migratory activity 
was higher in SMC derived from restenotio lesions than SMC derived from 
pdmary specimens (30 4-14 vs 19 ± 0.9 cells/HPF, p :  0.02). 
In conclusion: This study damonctrates that both primary and restenotic 
atherectomy specimens how low levels of ongoing proliferation with signif- 
icantly higher proliferative activity, higher explanted SMC growth rates and 
migratory activity in roetenotic than pdmary lesions suggesting that therapies 
aimed at controlling these processes am worthy of further investigation to 
reduce restenosis. 
9~'6"~"1  Conssnsuevlnterferon Inhibits Proliferation and 
Mlgrotlon of  Vascular Smooth Muscle Cells 
Rail P. K0eter, Michael St0rzl 1, Jan K~hter, Till v. Varendorff, 
Hans-Martin Stuloba, Woitram Terms, Christian W. Hamm, 
Thomas Mainertz. UntYersify Hospital Eppendoff, Dept. of C, ardiology, 
Hamburg, Germany; 1 Max Planck Institute for Biochemist~, Man;nsried, 
Germany 
Proliferation and migration of vascular smooth muscle cells (SMC) are major 
mechanisms in the pathogenesis of restenosi=. Consensus-lntertemn (clFN) 
is a new interferon-a derivative with high specific activity which has been 
implicated to regulate call proliferation and migration. In the present study 
we investigated the effects of clFN on proliferation and migration of SMC. 
Methods: SMC were cultivated from human aortic tissue. Ceils ware stim- 
ulated with 10% fetal calf samm (FCS) (n = 36) or pletelet-dedved growth 
factor-BB (PDGF-BB) (n = 12), a potent growth factor in restsnosis. SMC 
were incubated with clFN at concentrations of 0.01-10 ng/ml. Proliteration 
of cells was measured by counting cell numbers with an automated cell an- 
alyzer. Migration of SMC was determined by a modified Boyden chamber 
assay. 
Results: Proliferation of FCS-etimulated SMC was inhibited by clFN in a 
dose-dependent manner. Maximum inhibition was 56:1: 3% at a concentration 
of 10 ng/ml (p < 0,001). After withdrawal of clFN, the proliferation rate 
of cells returned to control level, suggesting a reversible mechanism of 
inhibition, Significant oxic side effects were not detected by trypan blue 
exclusion. PDGF-BB-stimuleted pmliferation of SMC was reduced by 51 
3% by clFN (p = 0.023), Immunocytochemtcal nalysis of cultivated SMC 
suggest that clFN inhibits the PDGF-BB-Induced expression of tho c-myc 
gena which has previously been demonstrated to modulate proliferation and 
migration of SMC. FCS-Induced migration of SMC was significantly inhibited 
by clFN in a dose-dependent fashion. Maximum inhibition was 48 ± 22% at 
a concentration of 10 ng/ml (p < 0.05). 
Conclusions: 1. Consensus-Interferon i hibits proliferation and migration 
of human vascular smooth muscle cells. 2. This inhibition may at least 
partially be explained by inhibition of c-myc gane expression by clFN. 3. 
CIFN treatment may be useful for the prevention of restenosis after coronary 
Interventions. 
